The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: A phase 2 study of intratumor pil-12 plus electroporation in combination with intravenous pembrolizumab in patients with stage III/IV mealanoma progressing on either pembrolizumab or nivolumab treatment (PISCES).
 
Robert Hans Ingemar Andtbacka
Honoraria - Aduro Biotech; Amgen; Merck/Schering Plough; Novartis
Consulting or Advisory Role - Aduro Biotech; Amgen; Merck/Schering Plough; Novartis
Research Funding - Amgen (Inst); Idera (Inst); Oncolys BioPharma (Inst); OncoSec (Inst); Provectus (Inst); Takara Bio (Inst); Viralytics (Inst); X4 Pharma (Inst)
 
Tom Van Hagen
Research Funding - OncoSec
 
Phillip Parente
Research Funding - OncoSec
 
Victoria Atkinson
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Igor Puzanov
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Merck
 
Gregory A. Daniels
Consulting or Advisory Role - Merck
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Nektar (Inst); Viralytics (Inst)
 
Sajeve Samuel Thomas
Research Funding - OncoSec
 
Anne Poh Long
Research Funding - OncoSec
 
Andrew Mark Haydon
Consulting or Advisory Role - Novartis
 
Arkadiusz Z. Dudek
Employment - Adhaere Pharmaceuticals
Leadership - IGF Oncology; Martell diagnostic
Stock and Other Ownership Interests - Biothera; IGF Oncology; Vanquish Oncology
Honoraria - Biothera; IGF Oncology; Medtronic; Vanquish Oncology
Consulting or Advisory Role - Biothera; TTC Oncology; Vanquish Oncology
 
Sharron Erna Gargosky
Employment - OncoSec
Leadership - OncoSec
Stock and Other Ownership Interests - OncoSec
 
Chris Twitty
Employment - OncoSec
Leadership - OncoSec
Stock and Other Ownership Interests - OncoSec
 
John M. Kirkwood
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Immunocore; Merck; Novartis; Roche
Research Funding - Merck (Inst); Prometheus (Inst)